3I
Schedule 13G filing
3i, LP disclosed a 9.9% stake in Valion Bio, Inc. (VBIO)
3i, LP reported owning 9.9% of Valion Bio, Inc. (VBIO) (132,671 shares) in a Schedule 13G filed Sep 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.